Evaluation of tDCS Efficacy in Enduring Anorexia Nervosa
NCT ID: NCT03813355
Last Updated: 2023-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
17 participants
INTERVENTIONAL
2020-10-21
2022-07-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objectives of the study will be to evaluate the efficacy of tDCS in anorexia nervosa resistant to conventional treatments on weight gain, eating behavior, psychological and nutritional behavioral scales, cognition, connectivity and brain activity.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcranial Direct Current Stimulation (tDCS) and Anorexia Nervosa
NCT02734108
New Treatment Perspectives in Adolescents With Anorexia Nervosa: the Efficacy of Non-invasive Brain-directed Treatment
NCT05674266
Transcranial Direct Current Stimulation (tDCS) in the Treatment of Anorexia Nervosa
NCT03273205
Intermittent Theta Burst Transcranial Magnetic Stimulation of the Right Parietal Lobe in Anorexia Nervosa
NCT07106645
Mechanisms of Deep Transcranial Magnetic Stimulation in Enhancing Cognitive-Behavioral Therapy for Anorexia Nervosa
NCT06942858
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active stimulation
Brain stimulation by Transcranial Direct Current Stimulation (tDCS) with active stimulations
transcranial Direct Current Stimulation (tDCS)
transcranial Direct Current Stimulation (tDCS) during 20 sessions
Sham stimulation
Brain stimulation by Transcranial Direct Current Stimulation (tDCS) with inactive stimulations
transcranial Direct Current Stimulation (tDCS)
transcranial Direct Current Stimulation (tDCS) during 20 sessions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transcranial Direct Current Stimulation (tDCS)
transcranial Direct Current Stimulation (tDCS) during 20 sessions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body Mass Index (BMI) \< 17kg/m2
* Conventional treatment failure over the last 12 months
* Refusal or no indication of artificial nutrition
Exclusion Criteria
* Other chronic diseases
* drug use (except tobacco)
* pregnancy
* Edinburgh score \< 14
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Catherine Massoubre, PhD
Role: PRINCIPAL_INVESTIGATOR
CHU SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Clermont-Ferrand
Clermont-Ferrand, , France
CHU Grenoble
Grenoble, , France
Hospices Civils de Lyon
Lyon, , France
CHU Saint-Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A02866-49
Identifier Type: OTHER
Identifier Source: secondary_id
1708195
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.